Fitlife Brands, Inc. SEC filings FTLF
Fitlife Brands, Inc. has 539 filings in SEC EDGAR's recent list, going back to Sep 7, 2006. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 9, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Jun 26, 2026 | — |
| DEFA14A | Additional proxy material | Jun 26, 2026 | — |
| DEF 14A | Proxy statement | Jun 26, 2026 | Aug 11, 2026 |
| DEFA14A | Additional proxy material | Jun 24, 2025 | — |
| DEF 14A | Proxy statement | Jun 24, 2025 | Aug 12, 2025 |
| DEFA14A | Additional proxy material | Jun 24, 2025 | — |
| DEF 14A | Proxy statement | Jul 5, 2024 | Aug 13, 2024 |
| DEF 14A | Proxy statement | Jun 30, 2023 | Aug 9, 2023 |
| DEF 14A | Proxy statement | Apr 28, 2021 | Jun 8, 2021 |
| DEF 14A | Proxy statement | Jul 12, 2019 | Aug 16, 2019 |
| DEFA14A | Additional proxy material | May 17, 2017 | — |
| DEF 14A | Proxy statement | May 1, 2017 | May 1, 2017 |
| DEF 14A | Proxy statement | Apr 30, 2015 | Apr 30, 2015 |
| DEF 14A | Proxy statement | May 29, 2014 | May 27, 2014 |
| DEF 14A | Proxy statement | Jun 12, 2013 | Jun 12, 2013 |
| PRE 14A | Preliminary proxy statement | May 31, 2013 | May 31, 2013 |
| DEF 14A | Proxy statement | Jul 28, 2010 | Aug 26, 2010 |
| PRE 14A | Preliminary proxy statement | Jul 7, 2010 | Jul 7, 2010 |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- FTLF (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Omaha, NE
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1374328
- Former names
- BOND LABORATORIES, INC. (until Oct 1, 2013)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.